Uterine leiomyoma is the most frequent gynecologic neoplasm in women. By using a panel of cell lines derived from spontaneous Eker rat leiomyomas, we examined the estrogen-responsive phenotype of these tumor cells. Leiomyoma-derived ELT cell lines proliferated in response to estrogen, and estrogen-i
Modulation of nonspecific cell-mediated growth inhibition by estrogen metabolites
β Scribed by Richard W. Pfeifer; Rachel M. Patterson
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 633 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0162-3109
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
2-Methoxyestradiol (2-ME 2 ) is a novel anticancer agent because of its ability to potentiate apoptotic cell death and inhibit cancer cell growth and angiogenesis. The modes of action of this agent, however, have not yet been fully elucidated. In our study, we have investigated whether 2-ME2 is able
## Abstract Curcumin (diferuloylmethane), which has been shown to inhibit growth of transformed cells, has no discernible toxicity and achieves high levels in colonic mucosa. 5βfluorouracil (5βFU) or 5βFU plus oxaliplatin (FOLFOX) remains the backbone of colorectal cancer chemotherapeutics, but wit
Melatonin inhibits the growth of breast cancer cells by interacting with estrogen-responsive pathways, thus behaving as an antiestrogenic hormone. Recently, we described that melatonin reduces aromatase expression and activity in MCF-7 human breast cancer cells, thus modulating the local estrogen bi
## Abstract The polyphenolic compounds curcumin and quercetin increased sensitivity of ovarian cancer cells (CAOV3 and SKOV3) to cisplatin. The effect was obtained when the compounds were added simultaneously with cisplatin, as well as when they were added 24 h before. High serum levels of certain